Finance Watch: Morningside Launches Adiso With More Than $60m In Early Funding
Start-Up Has Two Clinical-Stage Product Candidates
Private Company Edition: In addition to Adiso, Creyon recently launched with $40m and TRexBio extended its series A by $26m to $85m total. Also, Kurma Partners raised the first €160m of a planned €250m fund to back companies transitioning from R&D to commercial operations.
